This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
mobile: Archive
Should You Buy Vornado (VNO) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
VNOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Harmonic vs. Belden: Which Connectivity Stock is a Better Buy Now?
by Supriyo Bose
HLIT's broadband growth, stronger price gains and upbeat estimate revisions help it stand out over BDC despite a richer valuation.
HLITPositive Net Change BDCNegative Net Change
artificial-intelligence communications iot mobile tech-stocks
SpaceX Plummets 16.4% Yesterday: Bull Trap or Buying Opportunity?
by Supriyo Bose
SPCX's 16.4% plunge wiped out $400.8 billion as note issuance, AI deals and dilution fears tested confidence after its blockbuster IPO.
AMZNPositive Net Change MSFTPositive Net Change SPCXPositive Net Change ASTSPositive Net Change
artificial-intelligence communications iot mobile tech-stocks
Affirm Holdings (AFRM) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AFRMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Anterix Surges 163% in the Past Year: Should You Bet on the Stock?
by Supriyo Bose
ATEX's 163% surge, utility broadband push and 900 MHz spectrum edge spotlight its growth runway, but long utility sales cycles remain a risk.
ERICNegative Net Change BANDPositive Net Change ATEXPositive Net Change
artificial-intelligence communications iot mobile tech-stocks
Satellogic Rides on Healthy Demand Trends: Should You Buy the Stock?
by Supriyo Bose
SATL is riding rising Earth observation demand, defense contract momentum and AI-first satellite technology as the stock extends its six-month surge.
IRDMPositive Net Change GILTNegative Net Change SPCXPositive Net Change SATLPositive Net Change
artificial-intelligence communications iot mobile tech-stocks
Bandwidth Surges 258% in the Past Year: Should You Buy the Stock?
by Supriyo Bose
BAND's 258% surge reflects momentum from cloud communications, AI adoption, enterprise growth and global expansion, making it a high-flying stock.
ERICNegative Net Change BANDPositive Net Change ATEXPositive Net Change
artificial-intelligence communications iot mobile tech-stocks
SpaceX Juggernaut Continues: Should You Join the Bandwagon?
by Supriyo Bose
SPCX's blockbuster IPO, Starlink growth, government contracts and Anysphere deal are fueling its push across space, broadband and enterprise AI.
AMZNPositive Net Change MSFTPositive Net Change SPCXPositive Net Change ASTSPositive Net Change
artificial-intelligence communications iot mobile tech-stocks
Insight Enterprises (NSIT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
NSITPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Anysphere Buyout Drive SPCX Further After a Blockbuster IPO?
by Supriyo Bose
SpaceX's $60B Anysphere deal could boost its enterprise AI push after a $75B IPO, but execution risks and Cursor growth remain key tests.
AMZNPositive Net Change TSLAPositive Net Change SPCXPositive Net Change
artificial-intelligence communications iot mobile tech-stocks